Text Size

M
L

Language

JP
EN

About TEIKOKU SEIYAKU
About TEIKOKU SEIYAKU
Company
Company

News release

HOME
NEWS

2016.10.4

Execution of Basic Agreement for Sales Anti-Allergy Agent, Rupatadine Tablets

New Topics

Change in The Board of Directors
President and CEO Misako Fujioka In...
Change in The Board of Directors
Notice of Launch of ALLYDONE® Patch...
Manufacturing and Marketing Approva...
Execution of a license agreement on...
TEIKOKU SEIYAKU was selected as A G...
Change in The Board of Directors
Notice Launch of Rupafin® tablets i...
Notice regarding acquisition of man...

Backnumber

2025
2023
2022
2020
2017
2016

567 Sanbonmatsu, Higashikagawa, Kagawa 769-2695, Japan
TEL +81-879-25-2221

Contact us

Privacy(Japanese)
Sitemap

© 2024 Teikoku Seiyaku Co.,Ltd.

About TEIKOKU SEIYAKU

VISION2031
Patch Medication, Globally
For a World Without Pain
Hydrohesive®
A Familiar Company, Teikoku Seiyaku
International Focus
Plant
Laboratory
Teikoku Seiyaku Group
Locations

Message
Corporate Philosophy
Company Overview
Office Locations
History